28 March 2012

Warnings March 2012

Since the beginning of March we have a range of substances that are harmful to health tested. Apart from the tablets sold as ecstasy, which contained a large number of other substances in addition to the particularly harmful substance PMA (see here)are a series of other tablets with unexpected and questionable ingredients were handed in. All samples that have been handed in from 1 March to date at checkit! analysed and were classified as high-dose, unexpected or of particular health concern, you will find a detailed description here.

21 March 2012

PMA warnings March 2012

As already reported in our last warning article, on 16/17 March we analysed a total of 12 pills sold as ecstasy, which instead of the active ingredient MDMA contained, among other things, the particularly harmful substance PMA (paramethoxyamphetamine) contained. Photos of the analysed pills as well as detailed information on the analysed pills and their other ingredients can be found at here.

!!!Due to the large number of substances AND the active ingredient PMA, there is an increased risk of life-threatening poisoning!!!!

According to our information, there are probably more of these pills in circulation.
We therefore strongly advise against the consumption of untested substances!!!

17 March 2012

!!! Warning!!! PMA in ecstasy pills!!!

We have on 16 March 12 pieces of pill sold as XTCanalysed, which instead of the active ingredient MDMA contain, among other things, the substance PMA (paramethoxyamphetamine) contained. The pills are white (yellowed) and have pink and brown speckles; there is a logo on the front. The tablets also contained a large number of other substances (4-MEC, alpha PPP, mephedrone, pFPP, caffeine and two other substances).

!!!Due to the large number of substances AND the active ingredient PMA, there is an increased risk of life-threatening poisoning!!!!

According to our information, there are probably more pills in circulation!

Approximately one hour after taking PMA blood pressure and body temperature rise suddenly and sharply. PMA users feel a strong lower dosage The person undergoes an alcohol-like state of intoxication, perceives hallucinogenic-like afterimages and abnormal body sensations such as tingling, numbness or furry skin, limbs falling asleep and similar effects.

PMA can cause a sharp rise in blood pressure and body temperature. The pulse begins to race, breathing becomes faster and at the same time heavier, the eyes move abruptly, muscle cramps, nausea and vomiting can occur. The very sharp rise in body temperature can lead to organ failure with fatal consequence come.

If you experience these symptoms, please call the emergency services immediately (144)

!!! We strongly advise against the consumption of untested substances !!!

You can find more information about PMA here!

2 March 2012

Warnings January/February 2012

In the following, all allegedly psychoactive substances that have been recognised since the beginning of 2012 in checkit! analysed and classified as high-dose, unexpected or harmful to health. were classified as being of particular concern.

We first identified the Research Chemical 5-APB. It was detected both in a tablet sold as "ecstasy" and in a sample analysed as "speed". Further details can be found in the further information on the ingredients

In addition, we have for the first time Heroin in the form of a tablet analysed. These Dosage form is extremely unusual. If you have a brown tablet with dark speckles (no embossing), have it analysed if possible!

A detailed description of the warnings and the unexpected results can be found here!

15 November 2011

Warnings November 2011

ChEck iT! has since the beginning of November 16 samples of allegedly psychoactive substances tested. Several speed and cocaine samples had to be warned because of various admixtures. In addition, for the first time Propylamphetamine - a hitherto largely unexplored substance - was identified in samples submitted as "speed". A detailed description of the warnings and the unexpected results can be found here.

14 November 2011

High-dose XTC tablets !

14.11.2011
Possibly high-dose ecstasy tablets in circulation

Our Swiss colleagues from Safer Party recently tested several ecstasy tablets that contained MDMA in very high concentrations (over 200 mg). Such high-dose pills have already appeared in the Netherlands this year - it cannot be ruled out that such tablets are also in circulation here. At doses of this level, negative effects such as jaw cramps, muscle tremors, anxiety, frightening visions and orientation difficulties come to the fore. In individual cases, epileptic seizures may occur. The exact description of the warnings can be found here and here.

Should you decide to consume such a tablet, Have your tablet tested! If you don't have the opportunity, Test carefully (no more than half a tablet) and do not top up straight away. To avoid overdosing, the following guideline applies: maximum 1.5 mg MDMA per body weight per kilogramme for men and 1.3 mg MDMA per kilogramme for women. This means a maximum of 90 mg MDMA for a 60 kg man and 65 mg for a 50 kg woman. This is important for high-dose XTC tablets, but generally applies to all. Don't be fooled by the logo - if your tablet looks like one of these, be more careful with the dosage. However, you can never be sure that your tablet contains MDMA just by looking at it - so have it tested and, if in doubt, test it carefully!

ChEck iT! is neither responsible for the content of link pages nor for the content of subsequent link pages.

24. October 2011

Attention: Deaths after 4-methylamphetamine consumption!

In Belgium and Great Britain, it is known in connection with the substance 4-methylamphetamine (4-MA) intoxication with fatal consequences have arrived.

10. October 2011

Warnings Sept/Oct 2011

Check iT! has again identified a number of unexpected substances of health concern in the last two analyses. For the first time in September Methyl ethyl cathinone (4-MEC) was analysed in a substance purchased as mescaline and the substance was also present in the last test in October. We also analysed the piperazine derivative para-Fluorophenylpiperazine (pFPP) identified. For a detailed description of the October warnings click here. You can find the September warnings here.